多家美股上市公司配置比特币:ACXP 批准 1000 万美元购买计划,ENFN 拟配置 10% 现金

BTC-1,09%
ETH-2,68%

Gate News 消息,3 月 20 日,生物制药公司 Acurx Pharmaceuticals(纳斯达克代码:ACXP)批准 1000 万美元比特币购买计划,旨在利用比特币的抗通胀特性对冲长期研发资金贬值风险,实现财务多元化。

投资管理软件公司 Enfusion(纽交所代码:ENFN)计划将 10% 超额现金配置到比特币和以太坊,以提升风险调整后收益。此外,Nature’s Miracle(纳斯达克代码:NMHI)启动 500 万美元比特币储备计划,标志其将加密货币纳入储备资产。

某加密托管服务商报告称,其加密货币托管服务同比增长 40%,反映出越来越多非加密企业依赖合规托管方进入比特币市场。

Disclaimer: The information on this page may come from third parties and does not represent the views or opinions of Gate. The content displayed on this page is for reference only and does not constitute any financial, investment, or legal advice. Gate does not guarantee the accuracy or completeness of the information and shall not be liable for any losses arising from the use of this information. Virtual asset investments carry high risks and are subject to significant price volatility. You may lose all of your invested principal. Please fully understand the relevant risks and make prudent decisions based on your own financial situation and risk tolerance. For details, please refer to Disclaimer.
Commento
0/400
Nessun commento